| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226775 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 10 Pages |
Abstract
WAP-IMRT with concurrent radiosensitizing chemotherapy was well tolerated after aggressive surgery for DSCRT. Enhanced bone sparing with IMRT probably accounts for the low hematologic toxicity (vs. conventional WAP-RT). This modality should be considered as an additional local-regional control option for DSRCT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chelsea C. M.D., Ph.D., Hiral P. M.D., Andrea M.D., Vivek M.D., Stephen D. C.M.D., Eric L. M.D., David R. M.D., Ph.D., Mary F. M.D., Ph.D., Eric P. M.D., Ph.D., Shiao Y. M.D., Peter M.D., Ph.D., Holly L. B.S., Anita M.D.,